AI-generated · cited to primary sources · not investment advice
R&D spending is accelerating as the company scales its engineering headcount and technical testing to meet a 2027 deployment target. For the nine months ended Sept 30, 2024, R&D expenses rose 256% compared to the prior year period. (2 accelerating across 2 signals)
“R&D expenses increased by $13,971,678, or 256.0%, for the nine months ended September 30, 2024, compared to the nine months ended September 30, 2023.”
See the full cited Future Growth analysis of Oklo Inc. Class A common stock
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.